vialaudit
The Roundup
semax · connecticut

Is Semax legal in Connecticut?

status · caveats apply
No FDA approval (Russian-approved stroke/cognitive drug); PCAC under-review with vote scheduled July 24, 2026; not on WADA list. No state-level peptide restrictions beyond federal law in Connecticut.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

No FDA approval (Russian-approved stroke/cognitive drug); PCAC under-review with vote scheduled July 24, 2026; not on WADA list. No state-level peptide restrictions beyond federal law in Connecticut.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: under pcac review
Do-not-compound list: under pcac review
Was Category 2; removed in April 2026 administrative shuffle; now under formal PCAC review. Indications under review: cerebral ischemia, migraine, trigeminal neuralgia.
PCAC review history
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies. PCAC pending — current status is unapproved with formal review pathway opening.
Personal possession: Not federally criminalized.

Connecticut — state-specific

Sport-body status

WADA 2026
not on prohibited list
Not explicitly named.
USADA
not banned
NCAA
unknown

What we couldn’t verify

§ 03

Also known as

Semax is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Russian Semax
  • ACTH analogue (4-10)
  • Methionyl-Glutamyl-Histidyl-Phenylalanyl-Prolyl-Glycyl-Proline
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch